arrow
L

Livio Trentin

University of Padua
H指数:62
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Consolidative allogeneic stem cell transplantation following bispecific antibody salvage in relapsed/refractory high-grade B-cell lymphoma: representative cases and literature review

异基因干细胞移植巩固治疗继发于双特异性抗体解救治疗的复发/难治性高级别B细胞淋巴瘤:代表性病例及文献综述

2026-11-030
OAAI
Correction: Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study

更正:携带t(14;19)易位的慢性淋巴细胞白血病患者临床和转录组学特征:一项ERIC研究

Leukemia
IF13.4
2026-10-160
OAAI
Gene Expression, Non-Coding RNA, and Circular RNA Alterations in Patients with T-Prolymphocytic Leukemia

T-原淋巴细胞白血病患者中的基因表达、非编码RNA和环状RNA改变

Cancers
IF4.4
2026-07-300
OA
Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study

早期伊布替尼剂量调整在CLL中的应用:EVIdeNCE真实世界研究的回顾性分析

Cancers
IF4.4
2026-04-030
OAAI
Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R)

vemurafenib联合利妥昔单抗治疗复发或难治性毛细胞白血病的真实世界疗效与安全性:一项多中心意大利回顾性研究(HCL-PG03R)

2025-11-140
OAAI
An Uncommon Localization of Hairy Cell Leukemia: Central Nervous System Involvement and Response to Ibrutinib—A Case Report and a Review of the Literature

毛细胞白血病的不常见定位:中枢神经系统受累及伊布替尼的治疗反应——病例报告及文献综述

2025-10-310
OAAI
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study

携带t(14;19)易位的慢性淋巴细胞白血病患者临床及转录组学特征:一项ERIC研究

Leukemia
IF13.4
2025-09-190
OAAI
Interplay Between Protein Phosphatase 2A (PP2A) and SE Translocation (SET) as Macromolecular Target of Anticancer Compounds: A Combined Computational and Experimental Study

蛋白磷酸酶2A(PP2A)与SE易位(SET)的相互作用作为抗癌化合物的大分子靶点:一项结合计算和实验的研究

2025-09-120
OA
Serum soluble interleukin-2 receptor levels in hairy cell leukaemia as a marker of tumour burden with prognostic value and as a tool for disease monitoring

毛细胞白血病中血清可溶性白细胞介素-2受体水平作为肿瘤负荷标志物,具有预后价值,并作为疾病监测工具。

2025-07-290
OAAI
Transcriptomic landscape of CD8+ and CD4 + T-LGL leukemia revealed the distinct impact of STAT3 and STAT5B activating mutations

CD8+和CD4+ T-LGL白血病的转录组景观揭示了STAT3和STAT5B激活突变的独特影响

Leukemia
IF13.4
2025-07-280
OA
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms

特定疾病的U1剪接体RNA突变在成熟B细胞肿瘤中

Leukemia
IF13.4
2025-06-300
OAAI
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort

基于维奈克拉茨方案的八旬慢性淋巴细胞白血病患者:疗效、安全性及与BTKi的比较(多中心队列研究)

2025-04-240
OA
9p24/JAK2 rearrangements in myeloid neoplasms: from myelodysplastic syndromes to myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions

9p24/JAK2重排与髓系肿瘤:从骨髓增生异常综合征到伴有嗜酸性粒细胞增多和酪氨酸激酶基因融合的髓系/淋巴系肿瘤

2025-03-240
PRE
Activation- induced thrombospondin-4 works with thrombospondin-1 to build cytotoxic supramolecular attack particles

活化诱导的thrombospondin-4与thrombospondin-1协同作用,共同构建细胞毒性超分子攻击颗粒。

2025-02-040
OA
Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study
2024-12-250
OAAI
In-Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment
2024-12-100
PRE